132 related articles for article (PubMed ID: 37074866)
21. High-risk human papillomavirus DNA test results are useful for disease risk stratification in women with unsatisfactory liquid-based cytology pap test results.
Zhao C; Austin RM
J Low Genit Tract Dis; 2009 Apr; 13(2):79-84. PubMed ID: 19387127
[TBL] [Abstract][Full Text] [Related]
22. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
23. Which are more correctly diagnosed: conventional Papanicolaou smears or Thinprep samples? A comparative study of 9 years of external quality-assurance testing.
Cummings MC; Marquart L; Pelecanos AM; Perkins G; Papadimos D; O'Rourke P; Ross JA
Cancer Cytopathol; 2015 Feb; 123(2):108-16. PubMed ID: 25487287
[TBL] [Abstract][Full Text] [Related]
24. Quality improvement opportunities in gynecologic cytologic-histologic correlations: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 4.
Crothers BA; Jones BA; Cahill LA; Moriarty AT; Mody DR; Tench WD; Souers RJ
Arch Pathol Lab Med; 2013 Feb; 137(2):199-213. PubMed ID: 23368862
[TBL] [Abstract][Full Text] [Related]
25. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic correlation of the unsatisfactory Papanicolaou smear.
Ransdell JS; Davey DD; Zaleski S
Cancer; 1997 Jun; 81(3):139-43. PubMed ID: 9196011
[TBL] [Abstract][Full Text] [Related]
27. Update on the College of American Pathologists Experience With High-Risk Human Papillomavirus Proficiency Testing for Cytology.
Ghofrani M; Zhao C; Davey DD; Fan F; Husain M; Laser A; Ocal IT; Shen RZ; Goodrich K; Souers RJ; Crothers BA
Arch Pathol Lab Med; 2016 Dec; 140(12):1371-1374. PubMed ID: 27557412
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
29. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
30. Effects of transitioning from conventional methods to liquid-based methods on unsatisfactory Papanicolaou tests: results from a multicenter US study.
Owens CL; Peterson D; Kamineni A; Buist DS; Weinmann S; Ross TR; Williams AE; Stark A; Adams KF; Field TS
Cancer Cytopathol; 2013 Oct; 121(10):568-75. PubMed ID: 23658145
[TBL] [Abstract][Full Text] [Related]
31. Trends in Thyroid Fine-Needle Aspiration Cytology Practices: Results From a College of American Pathologists 2016 Practice Survey.
Mais DD; Crothers BA; Davey DD; Natale KE; Nayar R; Souers RJ; Blond BJ; Hackman S; Tworek JA
Arch Pathol Lab Med; 2019 Nov; 143(11):1364-1372. PubMed ID: 31100017
[TBL] [Abstract][Full Text] [Related]
32. Performance measures for Australian laboratories reporting cervical cytology 2009-2017: the impact of the national HPV vaccination program.
Ross J; Greaves J; Saville M; Earls P; Pagliuso J
Pathology; 2020 Aug; 52(5):522-528. PubMed ID: 32620288
[TBL] [Abstract][Full Text] [Related]
33. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
34. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
35. HPV Cotesting of Unsatisfactory Papanicolaou Tests: Implications for Follow-up Intervals.
Chen F; Hsu Lin L; Hindi I; Sun W; Shafizadeh N; Szeto O; Brandler TC; Simsir A
Am J Clin Pathol; 2023 Aug; 160(2):137-143. PubMed ID: 37052613
[TBL] [Abstract][Full Text] [Related]
36. The Tahoe Study: bias in the interpretation of Papanicolaou test results when human papillomavirus status is known.
Moriarty AT; Nayar R; Arnold T; Gearries L; Renshaw A; Thomas N; Souers R
Arch Pathol Lab Med; 2014 Sep; 138(9):1182-5. PubMed ID: 25171700
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.
Hong IS; Marshalleck J; Williams RH; Gaiter TE; Mielzynska-Lohnas I; Kim K
Acta Cytol; 2002; 46(5):828-34. PubMed ID: 12365215
[TBL] [Abstract][Full Text] [Related]
38. Cytomorphologic findings of cervical Pap smears from female-to-male transgender patients on testosterone therapy.
Williams MPA; Kukkar V; Stemmer MN; Khurana KK
Cancer Cytopathol; 2020 Jul; 128(7):491-498. PubMed ID: 32125771
[TBL] [Abstract][Full Text] [Related]
39. The role of monitoring interpretive rates, concordance between cytotechnologist and pathologist interpretations before sign-out, and turnaround time in gynecologic cytology quality assurance: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 1.
Clary KM; Davey DD; Naryshkin S; Austin RM; Thomas N; Chmara BA; Sugrue C; Tworek J
Arch Pathol Lab Med; 2013 Feb; 137(2):164-74. PubMed ID: 23368858
[TBL] [Abstract][Full Text] [Related]
40. Atrophic vaginitis: concordance and interpretation of slides in the College of American Pathologists Cervicovaginal Interlaboratory Comparison Program in Gynecologic Cytopathology.
Crothers BA; Booth CN; Darragh TM; Means MM; Souers RJ; Thomas N; Moriarty AT
Arch Pathol Lab Med; 2012 Nov; 136(11):1332-8. PubMed ID: 23106578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
